ABSTRACT
@#Optical coherence tomography angiography(OCTA), as a new imaging technology that has emerged in recent years, is characterized by non-invasiveness, high speed and high resolution. Compared with traditional contrast examination, OCTA is faster, safer and avoids the side effects and risks of traditional contrast agents. Now, OCTA has been gradually applied in the diagnosis, treatment and follow-up of eye diseases. Through real-time imaging of retinal choroidal blood vessels, this article reviews the research progress of clinical application of OCTA in diabetic retinopathy.
ABSTRACT
Optical coherence tomography angiography (OCTA) is a noninvasive angiography technique developed in recent years.Without using contrast medium,this technology can quickly and safely get retinal vascular images with relatively high-resolution.It has been widely used in the diagnosis and management of eye diseases,especially in the vascular diseases,such as diabetic retinopathy (DR),age-related macular degeneration (AMD),retinal central/branch venous obstruction (CRVO/BRVO),choroidal neovascularization(CNV),etc.This article reviews the clinical application of OCTA in diabetic retinopathy.
ABSTRACT
Drug deliver to the posterior eye segment (retinal tissue and vitreous) via systemic administration is constrained due to the presence of blood-retinal barrier (BRB) ,which regulates the permeation of many substances from blood to retina selectively.Two major transporters have been identified in the human genome,and they are solute carrier superfamilies and ATP-binding cassette.As the function of transporters is being revealed,it has been clarifed that the transporters are very important in pharmacokinetics.This article reviewed the expression and functional activity of various BRB transporters, including amino acid, oligopeptide, monocarboxylate, folate, nucleoside transporters etc.,updated the current knowledge about the BRB transporters and elucidated the urgent need for the development of optimal and efficient drug delivery systems.Any approach to further improving the ocular bioavailability of drugs will be of significant clinical relevance.